ConductScience.org, home

Paper8945698

Why would anyone have expected anything else? Characteristics of materials distributed by drug companies: four points of view.

Temple R and 1 other. J Gen Intern Med, 1996. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Why would anyone have expected anything else? Characteristics of materials distributed by drug companies: four points of view. Papers, record 8945698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8945698

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Why would anyone have expected anything else? Characteristics of materials distributed by drug companies: four points of view.
PubMed
Journal
J Gen Intern Med
PubMed
Year
1996
PubMed
Publication types
Comment, Editorial
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.25
iCite
Revised in PubMed
2019-05-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Temple RR
2O'Brien PP

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug IndustryMajor topic
Drug UtilizationMajor topic
Humans
United States
United States Food and Drug Administration

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on8945688Characteristics of materials distributed by drug companies. An evaluation of appropriateness.https://conductscience.org/library/papers/8945688

Source PubMed

Download CSV of comments and corrections

References1

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn Papers
18945688Characteristics of materials distributed by drug companies. An evaluation of appropriateness.J Gen Intern Med1996https://conductscience.org/library/papers/8945688

Source PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
11885831Selling drugs to the public--should the UK follow the example of the US?Br J Gen Pract2002https://conductscience.org/library/papers/11885831PubMed
11885830Selling drugs to doctors--it's marketing, not education.Br J Gen Pract2002https://conductscience.org/library/papers/11885830PubMed
10578674Pharmaceutical advertising revenue and physician organizations: how much is too much?West J Med1999https://conductscience.org/library/papers/10578674PubMed
8945699Drug companies and information about drugs: recommendations for doctors. Characteristics of materials distributed by drug companies: four points of view.J Gen Intern Med1996https://conductscience.org/library/papers/8945699PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8945698

GET https://conductscience.org/api/papers/v1/8945698/authors